← Back to Patent Explorer
US5035884A Expired / Lapsed US ⏱️ 0.0 years remaining

Methylene pyrrolidone copolymers for contact lens and pharmaceutical preparations

Assignee: Warner Lambert Co LLC
•
Filing: 1990-02-15
•
Granted: 1991-07-30
•
Expires: 2010-02-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A new series of copolymers which are useful as coatings for solid dosage forms, for transdermal devices, for wound dressing materials, and for contact lenses. Also disclosed are methods for preparing monomers and polymers as well as pharmaceutical compositions containing such polymers.

Inventors

  • 👤 Suk-Zu Song
  • 👤 Surendra C. Mehta
  • 👤 Kuchi S. Murthy
  • 👤 Russell U. Nesbitt
  • 👤 Mahdi B. Fawzi

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 22:07
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/70; A61K9/7023; A61K9/703; A61K9/7038; A61K9/7046; A61K9/7053; A61K9/20; A61K9/28; A61K9/2806; A61K9/2833; A61K9/284; A61K9/2846; A61K9/7061; A61L; A61L15/00; A61L15/16; A61L15/22; A61L15/24; C; C07; C07D; C07D207/00; C07D207/02; C07D207/30; C07D207/34; C07D207/36; C07D207/38; C08; C08F; C08F26/00; C08F26/06; G; G02; G02B; G02B1/00; G02B1/04; G02B1/041; G02B1/043

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 32 words
A method of using a copolymer of N-isopropyl-3-methylene-2-pyrrolidone and 2-hydroxyethylmethacrylate having an equilibrium water concentration of 36.5% by weight at room temperature in a transdermal delivery system for administration of a pharmaceutical.
Claim 2
Independent Claim 32 words
A method of using a copolymer of N-isopropyl-3-methylene-2-pyrrolidone and 2-hydroxyethylmethacrylate having an equilibrium water concentration of 36.5% by weight at room temperature in a transdermal delivery system for administration of a pharmaceutical.
Claim 3
Independent Claim 32 words
A method of using a copolymer of N-isopropyl-3-methylene-2-pyrrolidone and 2-hydroxyethylmethacrylate having an equilibrium water concentration of 36.5% by weight at room temperature for sustained release dosage forms for administration of a pharmaceutical.
Claim 4
Independent Claim 32 words
A method of using a copolymer of N-isopropyl-3-methylene-2-pyrrolidone and 2-hydroxyethylmethacrylate having an equilibrium water concentration of 36.5% by weight at room temperature for sustained release dosage forms for administration of a pharmaceutical.
Claim 5
Independent Claim 27 words
A method of using a copolymer of N-isopropyl-3-methylene-2-pyrrolidone and 2-hydroxyethylmethacrylate having an equilibrium water concentration of 36.5% by weight at room temperature in a soft contact lens.
Claim 6
Independent Claim 27 words
A method of using a copolymer of N-isopropyl-3-methylene-2-pyrrolidone and 2-hydroxyethylmethacrylate having an equilibrium water concentration of 36.5% by weight at room temperature in a soft contact lens.
Claim 7
Independent Claim 26 words
A method of using a copolymer of N-isopropyl-3-methylene-2-pyrrolidone and 2-hydroxyethylmethacrylate having an equilibrium water concentration of 36.5% by weight at room temperature as a wound dressing.
Claim 8
Independent Claim 26 words
A method of using a copolymer of N-isopropyl-3-methylene-2-pyrrolidone and 2-hydroxyethylmethacrylate having an equilibrium water concentration of 36.5% by weight at room temperature as a wound dressing.
Claim 9
Dependent Claim 28 words
A sustained release pharmaceutical composition comprising a pharmaceutical in combination with a copolymer N-isopropyl-3-methylene-2-pyrrolidone and 2-hydroxyethylmethacrylate having an equilibrium water concentration of 36.5% by weight at room temperature.
Claim 10
Dependent Claim 28 words
A sustained release pharmaceutical composition comprising a pharmaceutical in combination with a copolymer N-isopropyl-3-methylene-2-pyrrolidone and 2-hydroxyethylmethacrylate having an equilibrium water concentration of 36.5% by weight at room temperature.

References Cited (Backward Citations)

US3479327A Cited
US3452015A Cited
US3542778A Cited
US4593053A Cited
US4866148A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-07-29 1995-01-28 1995-07-30 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-07-29 1999-01-28 1999-07-30 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-07-29 2003-01-28 2003-07-30 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag